Identifying Cancers Impacted by CDK8/19
CDK8 and CDK19 Mediator kinases are transcriptional co-regulators implicated in several types of cancer. Small-molecule CDK8/19 inhibitors have recently entered or are entering clinical trials, starting with breast cancer and acute myeloid leukemia (AML). To identify other cancers where these novel...
| Published in: | Cells |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2019-08-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/8/8/821 |
